Browse the evidence

MetFlex to fat showed no correlation to MetFlex measured during the clamp.

Different methods may yield different insights into metabolic flexibility.

Approximately 83.0% of patients in both treatment groups receive TSH testing within a 1-year follow-up.

Practitioners should note that a high percentage of older adults on levothyroxine are monitored for TSH after initiating GLP-1 RAs.

TSH testing patterns did not differ between GLP-1 RAs and SGLT-2is.

Clinicians can expect similar TSH monitoring practices regardless of whether patients are on GLP-1 RAs or SGLT-2is.

The mean time to TSH testing was approximately 130.5 days for both groups.

Practitioners should be aware that TSH testing occurs on average about 130 days after treatment initiation.

Future research should standardize economic evaluation methods in SET studies for better comparison across diverse interventions, settings, and populations.

Researchers should aim for consistent evaluation methods to enhance the validity of findings in SET studies.

No significant findings emerged in White women, African American men, or for the 8-10 week outcomes regarding WCadjBMI or WHRadjBMI.

Results may not be generalizable to all demographic groups, indicating the need for tailored approaches in interventions.

Mean total costs per person-year decreased from $5227.25 to $4982.88 over three years.

Cost management strategies may be effective in obesity care over time.

Obesity has increased from 30.5% during 1999–2000 to 41.9% during 2017–2020.

Health practitioners should be aware of the rising obesity rates when designing interventions.

Diabetic nephropathy affects approximately 700 million people worldwide and is the leading cause of chronic kidney insufficiency.

Healthcare providers should be aware of the high prevalence of diabetic nephropathy in T2D patients.

There is significant societal attention on the issues of overweight and obesity.

Practitioners should be aware of the societal context when addressing obesity in patients.

There was no significant difference in the cost of diabetes therapy between the two groups (p = 0.12).

Practitioners can consider that an open formulary may improve glycemic control without increasing costs.

Effective nephroprotection requires early identification of at-risk patients through screening.

Implement routine screening for CKD risk factors in clinical practice.

Few diabetes prevention program (DPP) studies investigate why these interventions work.

Practitioners should be aware that the mechanisms behind DPP effectiveness are not well understood.

There is no compelling evidence to support any specific mechanism, mediator, or moderator (MMM) in DPPs.

Practitioners should consider that current evidence does not support specific mechanisms in DPPs.

About 14.9% of tweets contained untrue information, particularly in the nutrigenomics concepts category.

Practitioners should be aware of the prevalence of misinformation in social media discussions about precision nutrition.

26.2% of tweet authors presented themselves as science or medicine experts.

Practitioners should consider the credibility of sources when evaluating precision nutrition information on social media.

Nutrigenetics concepts were most frequently discussed by authors with science and medicine expertise.

Practitioners can identify credible discussions on nutrigenetics by focusing on expert authors.

Weekly telemonitoring for counseling and weigh-in does not lead to a statistically significant improvement in BMI over an 8-week period.

Practitioners may need to consider alternative interventions or longer durations for weight management programs.

Patients had lower energy and protein intake from oral food intake following the implementation of the tailored nutrition protocol.

Practitioners should be aware that increased enteral feeding may lead to reduced oral intake.

The EQUAL trial yielded null results in addressing weight management issues among acute lymphoblastic leukemia survivors.

Practitioners should be cautious in applying the EQUAL intervention for weight management in ALL survivors.

Cheeses improved C. elegans lifespan, mobility with aging, and age-related muscle degradation.

Incorporating these cheeses may support longevity and mobility in aging populations.

Hart- en vaatziekten zijn wereldwijd verantwoordelijk voor één op de drie overlijdens.

Dit benadrukt de noodzaak voor preventieve maatregelen tegen hart- en vaatziekten.

The association between T2D subgroups and MCI/PD was not modified by the Action for Health in Diabetes (Look AHEAD) lifestyle intervention.

Lifestyle interventions may not be sufficient to alter cognitive decline risks in certain T2D subgroups.

Concerns over ultra-processed foods were part of the holistic and environmental health movements of the 1970-80s.

Understanding the historical advocacy can inform current discussions on nutrition and health.